As such, whether an alternative effect on depression or anxiety disorders by the blockers of vasopressin V1B receptor as described previously (Iijima et al., 2014) is linked to their possible actions on multiple types of K+ currents remains to be essentially resolved. This evidence concerns the gene AVPR1B and depressive symptom measurement.